| Nov 14 |
Citi initiates coverage on 5 new biotech stocks
|
| Nov 14 |
Amgen speaks out about bone density concerns with obesity drug
|
| Nov 13 |
Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)
|
| Nov 13 |
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
|
| Nov 13 |
Amgen Rebounds, Shaking Off 'Overdone' Fears Tied To Its Weight-Loss Shot
|
| Nov 13 |
Amgen rebounds after denying bone safety concerns linked to obesity drug
|
| Nov 13 |
Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
|
| Nov 13 |
Amgen dismisses bone density concerns related to its new weight-loss drug
|
| Nov 13 |
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
|
| Nov 12 |
Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot
|
